Table II.

miRNA-218 expression in different subgroups of patients with cervical cancer (n=112).

Variables	Relative expression (Serum)	P-value	Relative expression (Tissue)	P-value
Age, yearsa		0.24		0.35
≤30 (n=12)	0.39±0.12		0.26±0.08
30–45 (n=55)	0.42±0.10		0.30±0.10
≥45 (n=45)	0.40±0.10		0.28±0.11
Age at menarche, yearsa		0.10		0.23
≤12 (n=20)	0.40±0.05		0.28±0.10
12–14 (n=68)	0.38±0.10		0.27±0.06
≥14 (n=24)	0.41±0.13		0.30±0.08
Menopausal status		0.18		0.10
Yes (n=32)	0.42±0.12		0.28±0.06
No (n=80)	0.40±0.08		0.31±0.10
Pregnancies, n		0.22		0.15
0–1 (n=82)	0.39±0.09		0.29±0.10
≥2 (n=30)	0.41±0.10		0.30±0.08
Deliveries, n		0.11
0–1 (n=88)	0.42±0.14		0.32±0.07	0.20
≥2 (n=24)	0.39±0.08		0.29±0.08
Family history of cancer, n		0.15		0.16
0–1 (n=6)	0.38±0.12		0.28±0.05
≥2 (n=106)	0.41±0.10		0.32±0.09

^aData are expressed as the mean ± standard deviation.